Teriflunomide-D4

CAT. No. L500009

CAS. No. 1185240-22-5

Teriflunomide-d4 is a deuterated form of teriflunomide, which is a medication used to treat multiple sclerosis (MS). Deuterated compounds contain deuterium, a stable isotope of hydrogen, in place of some or all of the regular hydrogen atoms in the molecule. Deuterated versions of drugs are sometimes used in pharmaceutical research and development to study the metabolism and pharmacokinetics of the drug in the body.

Teriflunomide, the non-deuterated form, is an immunomodulatory drug that is used to reduce the frequency of clinical exacerbations and slow the progression of disability in individuals with relapsing forms of MS. It works by inhibiting the proliferation of certain immune cells, particularly T-lymphocytes, which are thought to play a role in the inflammation and damage seen in MS.

Teriflunomide-d4, with the deuterium substitution, may be used in research settings to better understand the drug's metabolism and how it interacts with the body. This can help in improving the drug's efficacy and safety profiles. It is important to note that the use of deuterated compounds is typically restricted to scientific and pharmaceutical research and is not intended for regular clinical use by patients. If you have questions or need information about teriflunomide or its use in the treatment of MS, it is advisable to consult with a healthcare professional.

Simson Pharma is the leading manufacturer and exporter of Teriflunomide-d4. Buy Teriflunomide-d4 from Simson Pharma at best competitive price.